Anticoagulation Therapy during Extracorporeal Membrane Oxygenator Support in Pediatric Patients / 전남의대학술지
Chonnam Medical Journal
; : 110-117, 2017.
Article
in En
| WPRIM
| ID: wpr-151396
Responsible library:
WPRO
ABSTRACT
Extracorporeal membrane oxygenation (ECMO) is a salvage therapy for critically ill patients. Although ECMO is becoming more common, hemorrhagic and thromboembolic complications remain the major causes of death in patients undergoing ECMO treatments. These complications commence upon blood contact with artificial surfaces of the circuit, blood pump, and oxygenator system. Therefore, anticoagulation therapy is required in most cases to prevent these problems. Anticoagulation is more complicated in pediatric patients than in adults, and the foreign surface of ECMO only increases the complexity of systemic anticoagulation. In this review, we discuss the pathophysiology of coagulation, anticoagulants, and monitoring tools in pediatric patients receiving ECMO.
Key words
Full text:
1
Index:
WPRIM
Main subject:
Oxygen
/
Oxygenators
/
Oxygenators, Membrane
/
Pediatrics
/
Extracorporeal Membrane Oxygenation
/
Cause of Death
/
Salvage Therapy
/
Critical Illness
/
Membranes
/
Anticoagulants
Limits:
Adult
/
Humans
Language:
En
Journal:
Chonnam Medical Journal
Year:
2017
Type:
Article